Skip to main content
Holiday Sale — Get 40% off Vantage for yourself or as a gift
Get Started
SubscribeLogin
Published • loading... • Updated

UW joins industry-academia alliance to accelerate research in neuroscience

Summary by Ground News
The University of Washington has joined the Alliance for Therapies in Neuroscience (ATN) The ATN seeks to accelerate the development of new therapies for a broad range of brain and central nervous system conditions. As part of the ATN, Genentech and Roche committed up to $53 million over 10 years for research.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.Cross Cancel Icon

1 Articles

UW HomepageUW Homepage

UW joins industry-academia alliance to accelerate research in neuroscience

The University of Washington has joined the Alliance for Therapies in Neuroscience (ATN), a long-term research partnership between academia and industry geared to transform the fight against brain...

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

UW Homepage broke the news in on Monday, September 26, 2022.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Neuroscience icon

Neuroscience

University of Waterloo icon

University of Waterloo

Health & Medicine icon

Health & Medicine

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal